152 completed, 35 unknown, 34 terminated, 10 withdrawn. 239 Phase 2, 24 Phase 1, 3 Phase 3.
Follow Conventional Surgery: new trials by email Literature Review of Conventional Surgery trials Research Report on Conventional Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma Atezolizumab, Biospecimen Collection, Conventional Surgery - Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 61 | 2022-03-11 | 2026-11-13 |
| Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement Binimetinib, Conventional Surgery, Encorafenib - Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node | Phase 2 | Terminated | ECOG-ACRIN Cancer Research Group | 3 | 2021-09-22 | 2026-10-06 |
| Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer Conventional Surgery, Dabrafenib, Intensity-Modulated Radiation Therapy - Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Squamous Cell Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 30 | 2021-06-24 | 2026-10-08 |
| Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma Atezolizumab, Conventional Surgery, Fluorouracil - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 43 | 2019-02-19 | 2026-07-28 |
| Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Gemcitabine Hydrochloride, Cisplatin, Pegfilgrastim - Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma | Phase 2 | Active not recruiting | Alliance for Clinical Trials in Oncology | 237 | 2018-12-10 | 2026-10-16 |
| Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer Capecitabine, Chemotherapy, Conventional Surgery - Gastric Adenocarcinoma, Oligometastasis | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 100 | 2018-02-19 | 2026-10-06 |
| Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma Conventional Surgery, Ipilimumab, Laboratory Biomarker Analysis - Cervical Carcinoma, Esophageal Carcinoma | Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2017-11-03 | 2018-10-03 | |
| Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR Dasatinib, Conventional Surgery, Laboratory Biomarker Analysis - Breast Neoplasms, Triple Negative Breast Neoplasms | Phase 2 | Terminated | University of Wisconsin, Madison | 5 | 2017-05-03 | 2022-06-03 |
| Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery Cetuximab, Cetuximab-IRDye 800CW, Tumor resection - Brain Neoplasm, Malignant Glioma | Phase 1 / Phase 2 | Terminated | Eben Rosenthal | 3 | 2016-10-01 | 2020-03-31 |
| Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer Conventional Surgery, Complete mesocolic excision with central vascular ligation - Colon Cancer | Phase 2 / Phase 3 | Unknown | Mansoura University | 40 | 2014-09-01 | 2018-08-16 |
| Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ letrozole, MRI, conventional surgery - Breast Cancer | Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 108 | 2012-02-01 | 2018-03-27 |
| Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer Biopsy, Conventional Surgery, Genetic Testing - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 1100 | 2011-05-31 | 2026-09-18 |
| Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor imatinib mesylate, conventional surgery - Gastrointestinal Stromal Tumor | Phase 2 | Completed | Peking University | 20 | 2010-05-01 | 2015-02-03 |
| Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer fluorouracil, leucovorin calcium, oxaliplatin - Colorectal Cancer | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 248 | 2008-08-01 | 2026-01-14 |
| Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery cetuximab, capecitabine, fluorouracil - Colorectal Cancer | Phase 2 | Terminated | UNICANCER | 19 | 2007-10-29 | 2020-02-11 |
| Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer bevacizumab, capecitabine, cisplatin - Oesophagogastric Cancer | Phase 2 / Phase 3 | Unknown | Professor David Cunningham | 1103 | 2007-10-01 | 2016-12-01 |
| Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer Everolimus, conventional surgery - Prostate Cancer | Phase 2 | Terminated | Jorge A. Garcia, MD | 17 | 2007-09-01 | 2018-12-06 |
| Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery cetuximab, cisplatin, fluorouracil - Esophageal Cancer | Phase 1 / Phase 2 | Completed | Federation Francophone de Cancerologie Digestive | 33 | 2007-07-01 | 2016-05-30 |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery bevacizumab, cetuximab, fluorouracil - Colorectal Cancer, Metastatic Cancer | Phase 2 | Unknown | Centre Hospitalier Universitaire Vaudois | 35 | 2007-06-01 | 2009-08-07 |
| Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery erlotinib hydrochloride, conventional surgery, immunohistochemistry staining method - Intraductal Papillary Mucinous Neoplasm of the Pancreas, Recurrent Pancreatic Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 6 | 2007-06-01 | 2014-10-16 |
Showing 20 of 239. Sign in to see all of them.
Breast Neoplasms (30) · Colorectal Neoplasms (24) · Central Nervous System Neoplasms (23) · Rectal Neoplasms (23) · Esophageal Neoplasms (21) · Sarcoma (19) · Adenocarcinoma Of Esophagus (18) · Carcinoma, Non-Small-Cell Lung (18) · Lung Neoplasms (18) · Colonic Neoplasms (17) · Glioblastoma (17) · Brain Neoplasms (16) · Gliosarcoma (16) · Head and Neck Neoplasms (16) · Neoplasm Metastasis (16)
National Cancer Institute (NCI) (17) · European Organisation for Research and Treatment of Cancer - EORTC (11) · Memorial Sloan Kettering Cancer Center (11) · M.D. Anderson Cancer Center (10) · Radiation Therapy Oncology Group (10) · Children's Oncology Group (9) · Roswell Park Cancer Institute (8) · SWOG Cancer Research Network (8) · Alliance for Clinical Trials in Oncology (7) · Case Comprehensive Cancer Center (6) · Children's Cancer and Leukaemia Group (5) · City of Hope Medical Center (5) · Fox Chase Cancer Center (4) · GERCOR - Multidisciplinary Oncology Cooperative Group (4) · Jonsson Comprehensive Cancer Center (4)
United States (177) · Canada (22) · United Kingdom (19) · France (18) · Switzerland (14) · Belgium (13) · Australia (10) · Netherlands (10) · Italy (9) · Germany (8) · Puerto Rico (8) · Austria (6) · Spain (6) · Sweden (6) · Ireland (4)
A. Bapsi Chakravarthy, MD (2) · Aminah Jatoi, MD (2) · Burton L. Eisenberg, MD (2) · Colin P. Dinney, MD (2) · David Cunningham, MD (2) · David J. Adelstein, MD (2) · David J. Perry, MD (2) · David Paul Kelsen, MD (2) · Frank Berthold, MD (2) · Gene David Resnick, MD (2) · Jeffry Alger, PhD (2) · Kevin G. Billingsley, MD (2) · Lawrence P. Leichman, MD (2) · Merrill S. Kies, MD (2) · Paul A. Meyers, MD (2)
PMID 25057165, PMID 11241082, PMID 11857322, PMID 11904735, PMID 14508361, PMID 14520092, PMID 14673042, PMID 15533252, PMID 15565574, PMID 15646530, PMID 15999362, PMID 16116597, PMID 16200343, PMID 16382125, PMID 16399443, PMID 16446334, PMID 16446336, PMID 16624554, PMID 16826357, PMID 16921048, PMID 17030548, PMID 17235046, PMID 17429100, PMID 17761982, PMID 17921712, PMID 17947728, PMID 18191528, PMID 18270337, PMID 18418009, PMID 18565686, PMID 18645482, PMID 18783876, PMID 18845990, PMID 18942073, PMID 19100600, PMID 19171715, PMID 19604722, PMID 19720915, PMID 19770418, PMID 19816190, PMID 19917840, PMID 20461765, PMID 20525721, PMID 20572040, PMID 20576718, PMID 20975604, PMID 21135251, PMID 21156335, PMID 21172879, PMID 21205757
P30CA043703 (8), U10CA032102 (8), P30CA033572 (6), P30CA006927 (4), P30CA016672 (4), P30CA006973 (3), U10CA098543 (3), U10CA180821 (3), 2004 (2), P30CA015083 (2), P30CA021765 (2), P30CA036727 (2), U10CA021115 (2), U10CA025224 (2), U10CA027469 (2)